Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-20-096190
Filing Date
2020-08-17
Accepted
2020-08-17 19:03:28
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 tm2028857d1_424b3.htm 424B3 549264
2 GRAPHIC image_001.jpg GRAPHIC 2735
  Complete submission text file 0001104659-20-096190.txt   554268
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

EIN.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-227786 | Film No.: 201111217
SIC: 2834 Pharmaceutical Preparations